Skip to Main Content

Paper Details

Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis.
Frontiers in Immunology
3
2022
CRD42022345584, GI-aGVHD, GVHD, Vedolizumab, acute gastrointestinal graft-versus-host disease, graft-versus-host disease, impaired metabolism, infections, nutritional complications, participants, patients, vedolizumab
Author NameAffiliation
Ashwin N AnanthakrishnanMassachusetts General Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2